Efficacy of citicoline as an acute stroke treatment

Expert Opinion on Pharmacotherapy

Volumn 10, Issue 5, 2009, Pages 839-846

  Clark, Wayne M ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Oregon Stroke Center   (United States)

Author keywords

Acute stroke; CDP choline; Citicoline; Neuroprotection; Stroke recovery

Indexed keywords

CITICOLINE; PLACEBO;

AMNESIA; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG COST; DRUG EFFICACY; DRUG FATALITY; DRUG METABOLISM; DRUG SAFETY; EXPERIMENTAL STUDY; HUMAN; MEMORY DISORDER; META ANALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PROBABILITY; REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION; UNITED STATES; VERBAL MEMORY;

ANIMALS; CYTIDINE DIPHOSPHATE CHOLINE; HUMANS; NOOTROPIC AGENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE; TREATMENT OUTCOME;

EID: 67649579964     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656560902765652     Document Type: Review

References (56)

1. D'Orlando KJ, Sandage BW Jr. Citicoline (CDP-choline): mechanisms of action and effects in ischemic brain injury. Neurol Res 1995;17:281-284
2. Secades JJ, Lorenzo JL. Citicoline: pharmacological and clinical review, 2006 update. Methods Find Exp Clin Pharmacol 2006;(Suppl B):1-56
3. Rao AM, Hatcher JF, Dempsey RJ. CDP-choline: neuroprotection in transient forebrain ischemia of gerbils. J Neurosci Res 1999;58:697-705
4. Kennedy EP. The metabolism and function of complex liquids. Harvey Lect 1963;57:143-171
5. Bazan NG Jr. Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochim Biophys Acta 1970;218:1-10
6. Yatsu FM, Moss SA. Brain lipid changes following hypoxia. Stroke 1971;2:587-593
7. Majeswska MD, Strosznajder J, Lazarewicz J. Effect of ischemic anoxia and barbiturate anesthesia on free radical oxidation of mitochondrial phospholipids. Brain Res 1976;110:547-557
8. Trovarelli G, DeMedio GE, Dorman RV, et al. Effect of cytidine diphosphate choline (CDP-choline) on ischemia-induced alterations of brain lipid in the gerbil. Neurochem Res 1981;6:821-833 (Pubitemid 12247640)
9. Dorman RV, Dabrowiecki Z, DeMedio GE, et al. Control of lipid metabolism in ischemic brain CDPamines. In: Horroks LA, Ansell GB, Porcellati G, editors, Phospholipids in the nervous system, vol I: Metabolism. New York: Raven Press Publishers, 1982. p. 123-135
10. López-Coviella I, Agut J, Savci V, et al. Evidence that 5′-cytidinediphosphocholine can affect brain phospholipid composition by increasing choline and cytidine plasma levels. J Neurochem 1995;65(2):889-894
11. Savci V, Goktalay G, Cansev M, et al. Intravenously injected Citicoline increases blood pressure and reverses hypotension in haemorrhagic shock: effect is mediated by central cholinergic activation. Eur J Pharmacol 2003;468(2):129-139 (Pubitemid 36556256)
12. Alkan T, Kahveci N, Goren B, et al. Ischemic brain injury caused by interrupted versus uninterrupted occlusion in hypotensive rats with subarachnoid hemorrhage: neuroprotective effects of citicoline. Arch Physiol Biochem 2001;109(2):161-167 (Pubitemid 33701917)
13. Weiss GB. Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline. Life Sci 1995;56(9):637-660
14. Kakihana M, Fukuda N, Suno M, Nagaoka A. Effects of CDP-choline on neurologic deficits and cerebral glucose metabolism in a rat model of cerebral ischemia. Stroke 1988;19:217-222 (Pubitemid 18084396)
15. Dorman RV, Dabrowieki Z, Horrocks LA. Effects of CDP choline and CDP ethanolamine on the alterations in rat brain lipid metabolism induced by global ischemia. J Neurochem 1983;40:276-279 (Pubitemid 13151637)
16. Yamamoto M, Shimizu M, Okamiya H. Pharmacological actions of a new TRH analogue, YM-14673, in rats subjected to cerebral ischemia and anoxia. Eur J Pharmacol 1990;181:207-214 (Pubitemid 20185892)
17. Boismare F, Le Poncin, Lefitte M, Rapin JR. Hemodynamic, functional, and biochemical effects of hypobaric hypoxia in rats treated with cytidine diphosphocholine. Abstract presented at the comptes rendus des seances de las societe de biologie. 1978;172:651 (Pubitemid 9087192)
18. Hamdorf G, Cervos-Navarro J. Study of the effects of oral administration of CDP-choline on open-field behaviour under conditions of chronic hypoxia. Arzneim-Forsch/Drug Res 1990;40:519-522 (Pubitemid 20177459)
19. De Medio GE, Brunett M, Dorman RV,et al. Phospholipid metabolism during central and peripheral damage and recovery in nervous tissue. Birth defects: original article series 1983;19:175-187
20. Mykita S, Golly F, Dreyfus H, et al. Effect of CDP-choline on hypocampic neurons in culture. J Neurochem 1986;47:223-231 (Pubitemid 16069194)
21. Aronowski J, Strong R, Grotta JC. Citicoline for treatment of experimental focal ischemia: histologic ad behavioral outcome. Neurol Res 1996;18(6):570-574 (Pubitemid 27009396)
22. Hurtado O, Pradillo JM, Fernández-López D, et al. Delayed post-ischemic administration of CDP-choline increases EAAT2 association to lipid rafts and affords neuroprotection in experimental stroke. Neurobiol Dis 2008;29(1):123-131 (Pubitemid 350180488)
23. Krupinski J, Slevin M, Badimon L. Citicoline inhibits MAP kinase signalling pathways after focal cerebral ischaemia. Neurochem Res 2005;30(8):1067-1073 (Pubitemid 41570042)
24. Hurtado O, Cárdenas A, Pradillo JM, et al. A chronic treatment with CDP-choline improves functional recovery and increases neuronal plasticity after experimental stroke. Neurobiol Dis 2007;26(1):105-111 (Pubitemid 46436490)
25. Alonso de Leciñana M, Gutiérrez M, Roda JM, et al. Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke. J Neurol Sci 2006;247(2):121-129 (Pubitemid 44301259)
26. Goyas ,Tazaki Y, Sakai F, Otomo E, et al. Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study. Stroke 1988;19:211-216 (Pubitemid 18084395)
27. Boudouresques AB, Michel B. Therapeutic conduct in light of a cerebral vascular accident and the use of CDP-choline. Abstract presented at the International Symposium: brain suffering and precursors of phosholipids. January 18, 1980; Paris
28. Tazaki Y, Sakai F, Otomo E, et al. Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study. Stroke 1988;19:211-216 (Pubitemid 18084395)
29. Corso A, Arena M, Ventimiglia A, et al. CDP-choline for cerebrovascular disorders: clinical evaluation and evaluation of electrophysiological symptomology. CL Terap 1982;102:379-386
30. Clark W, Warach S, Pettigrew L, et al. A randomized dose response trial of citicoline in acute ischemic stroke patients. Neurology 1997;49:671-678 (Pubitemid 27428003)
31. Clark W, Williams B, Selzer K, et al. A randomized efficacy trial of citicoline in patients with acute ischemic stroke. Stroke 1999;30:2592-2597
32. Brott T, Adams H, Olinger C. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989;20:864-870 (Pubitemid 19188240)
33. van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-607 (Pubitemid 18126965)
34. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. MD State Med J 1965;14(2):61-65
35. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587
36. Warach S, Pettigrew LC, Dashe JF, et al. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Ann Neurol 2000;48:713-722 (Pubitemid 30823221)
37. Clark W, Wechsler L, Sabounjian L, Schwiderski U. A phase III randomized efficacy trial of 2000mg Citicoline in acute ischemic stroke patients. Neurology 2001:57:1595-1602 (Pubitemid 33055476)
38. Davalos A, Castillo J, Clark W, et al. Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke 2002;33(12):2850-2857 (Pubitemid 35462855)
39. Weir B. The clinical problem of intracerebral hemorrhage. Stroke 1993;24:I93
40. Heiskanen O. Treatment of spontaneous intracerebral and intracerebellar hemorrhages. Stroke 1993;24:I94-5 (Pubitemid 23350063)
41. Yang G, Betz AL, Chenevert TL, et al. Experimental intracerebral hemorrhage: relationship between brain edema, blood flow, and blood-brain barrier permeability in rats. J Neurosurg 1994;81:93-102 (Pubitemid 24195513)
42. Kobari M, Gotoh F, Tomita M, et al. Bilateral hemispheric reduction of cerebral blood volume and blood flow immediately after experimental cerebral hemorrhage in cats. Stroke 1988;19:991-996 (Pubitemid 18203992)
43. Nath FP, Kelly PT, Jenkins A, et al. Effects of experimental intracerebral hemorrhage on blood flow, capillary permeability, and histochemistry. J Neurosurg 1987;66:555-562 (Pubitemid 17059511)
44. Mendelow A. Mechanisms of ischemic brain damage with intracerebral hemorrhage. Stroke 1993;24:I15-I17 (Pubitemid 23350067)
45. Clark W, Gunion-Rinker L, Lessov N, Hazel K. Citicoline treatment for experimental intracerebral hemorrhage in mice. Stroke 1998;29:2136-2140 (Pubitemid 28443531)
46. Secades JJ, Alvarez-Sabín J, Rubio F, et al. Citicoline in intracerebral haemorrhage: a double-blind, randomized, placebo-controlled, multi-centre pilot study. Cerebrovasc Dis 2006;21(5-6):380-385 (Pubitemid 44617305)
47. Iranmanesh F, Vakilian A. Efficiency of citicoline in increasing muscular strength of patients with nontraumatic cerebral hemorrhage: a double-blind randomized clinical trial. J Stroke Cerebrovasc Dis 2008;17(3):153-155 (Pubitemid 351626615)
48. Role of intravenous citicoline for supratentorial hemorrhage. Presented at the 27th International Stroke Conference February 2002
49. Agnoli A, Bruno G, Fioravanti M, et al. Therapeutic approach to senile memory impairment: a double-blind clinical trial with CDP choline. In: Wurtman RJ, Corkin S, Growden JH, editors, Alzheimer's disease: Proceedings of the Fifth Meeting of the International Study Group on the Pharmacology of Memory Disorders Associated with Aging. Boston, MA: Birkhauser; 1989. p. 649-654
50. Spiers PA, Myers D, Hochanadel GS, et al. Citicoline improves verbal memory in aging. Arch Neurol 1996;53:441-448 (Pubitemid 26143644)
51. Spiers PA, Myers D, Hochanadel GS, et al. Citicoline improves verbal memory with aging. Arch Neurol 1996;53(5):441-448 (Pubitemid 26143644)
52. Fioravanti M, Yanagi M. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database Syst Rev 2005;(2):CD000269. Review
53. Fresta M, Puglisi G. Reduction of maturation phenomenon in cerebral ischemia with CDP-choline-loaded liposomes. Pharm Res 1999;16(12):1843-1849 (Pubitemid 30040700)
54. Fresta M, Puglisi G, Di Giamcomo C, Russo A. Liposomes an in-vivo carriers for citicoline: effects on rat cerebral post-ischemic reperfusion. J Pharm Pharmacol 1994;46(12):974-981
55. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359(13):1317-1329
56. Clark W, Wissman S, Albers G, et al. The ATLANTIS study: recombinant tissue plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. A randomized, double-blind, placebo-controlled trial. JAMA 1999;282:2019-2026